Navigation Links
Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc.
Date:1/8/2009

TORONTO, Jan. 8 /PRNewswire-FirstCall/ - Med-Emerg International Inc. (OTCBB:MDER) ("MedEmerg"), one of Canada's leading providers of health services, is pleased to announce that its shareholders have voted in favour of the previously announced plan of arrangement (the "Arrangement") with AIM Health Group Inc. ("AIM") at a special meeting of MedEmerg's shareholders held in Toronto today. In excess of 90% of the votes cast at the meeting were in favour of the Arrangement.

The completion of the Arrangement remains subject to a final hearing by the Ontario Superior Court of Justice, currently expected to take place on January 13, 2009, and satisfaction of certain additional closing conditions.

About Med-Emerg International Inc.

MedEmerg specializes in the coordination and delivery of health care services in Canada. These services include an integrated chronic pain management program, community-based infusion centers and health human resource management, including physician and nurse staffing.

MedEmerg's audited revenue for its fiscal year ended December 31, 2007 was approximately US$22 million.

(www.medemerg.com)

Caution Concerning Forward-Looking Statements

Certain statements in this press release are forward-looking statements, including, but not limited to, those relating to the proposed transaction, the timing of the closing of the proposed transaction and other statements that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "plan", "expect", "believe", "intend", "anticipate", "forecast", "target", "estimate" and similar expressions identify forward-looking statements. Forward-looking statements are based on assumptions made by and information currently available to MedEmerg. Investors are cautioned that these forward-lookin
'/>"/>

SOURCE Med-Emerg International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
2. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
3. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
4. United Medicorp, Inc.s Shareholders Approve All Proposals
5. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
6. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
7. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
8. Flextronics Shareholders and Solectron Stockholders Approve Acquisition
9. Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction
10. Lafley Tells Shareholders That P&G is Designed to Grow
11. Manor Care Shareholders Vote to Approve $6.3 Billion Carlyle Buyout
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...http://www.EvasVillage.org ), the Paterson, New Je...ichael Jackson Film Print of "Thriller" ...NJ (PRWEB) July 3, 2009 -- Eva,s Village ( http://...i-poverty charity, seeks serious inquiries only fo...uot;Thriller" music video., , , , ,For infor...
(Date:7/3/2009)...opportunity for you to change your life - After ju... will experience a noticeable relief from the terr...terol levels and blood pressure will return to nor...ill finally be freed from the health concerns that..., Miami, FL (PRWEB) July 3...
(Date:7/2/2009)...echnology Institute (BTI) have made a novel discov...molecule" (FAIM), protects both immune and liver c... Their research is published in the current journ...tists, Jianxin Huo, Ph.D., and Shengli Xu, Ph.D., ...manipulated for clinical application and proposed ...
(Date:7/2/2009)... -- Pro-life forces won an important battle yester...state law regulating that abortion centers must pr...86 (also known as the "abortion pill") in order to..., The ruling came in Rogers v. Planned Parenthoo...w requiring that those administering RU-486 comply...
Breaking Medicine News(10 mins):Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 4Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 5Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 4Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2
...rding to a Journal of Bone and Mineral Research st...apolis (IUPUI) researchers, exercise when young ma...udy is now available in an advance online edition ...t edition in 2007. 'Our study demonstrates that ...
...rding to a International Labor Organization (ILO) ... 3 million people are unable to work partially or ...t due to its spread. ILO added that the virus had ...any countries. The spread of the virus has among ...
...w equipment, the ‘Radio Allergo Sorbent Test’ (RAS.../, Chennai, to help physicians track down the sour... effort to reject any substance, which it perceive...asthma, allergic rhinitis, digestive disturbances,...
...ntists at Kings College, London have developed a n...ng sex.// The concept on which the drug is based o...le in the vas deferens is prevented, thus sperms a... penis. This method of contraception is based on ...
Other Medicine News:Health News:Exercise In Childhood Provides Lifelong Benefits 2Health News:ILO Reports On The Crippling Effects Of HIV On The Workforce 2
(Date:6/28/2009)...gland and TOKYO, June 29 , ...es , Sosei Group Corporation ("Sosei"; TSE ...ura"; LSE: VEC) announce the commencement of a Pha... once-daily, long-acting muscarinic,antagonist (L...onary disease,(COPD). NVA237 is a dry powder form...
(Date:6/26/2009)...lease, "Agendia,s Breast Cancer Recurrence Test Ma...ert Consensus Recommendations" issued,on 23 Jun 2...lease be advised,that the subheadline was missing...R Newswire. Complete, corrected release follows: ,...east Cancer Recurrence Test MammaPrint Included in...
(Date:6/25/2009)...d Medical Experts Slated to Attend First National ...wire/ -- The first national symposium designed to ...e held next week in New York City when thirteen to...from their respective fields. The SUNY Youth Spor...on the health impacts that the $5 billion-a-year e...
(Date:6/25/2009)...ves Patent Covering ARIKACE for Once-Daily Treatme...JUNCTION, N.J., June 25 Cystic Fib...affiliate of the Cystic Fibrosis Foundation, has p... the continued development of ARIKACE(TM) (liposom...ms to treat Pseudomonas lung infections in cysti...
Breaking Medicine Technology:Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4/C O R R E C T I O N -- Agendia B.V./ 2/C O R R E C T I O N -- Agendia B.V./ 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 4Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 2Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 3Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 4How to stop regaining weight 3F Thats the real question 3090 1How to stop regaining weight 3F Thats the real question 3090 2Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A 26M Health Science Center 1915 1Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A 26M Health Science Center 1915 2BIO key 28R 29 Granted Image Identification System Patent for Award Winning Biometric Technology 3088 1BIO key 28R 29 Granted Image Identification System Patent for Award Winning Biometric Technology 3088 2BIO key 28R 29 Granted Image Identification System Patent for Award Winning Biometric Technology 3088 3Springer publishes anthology with the Nanoethics Group 4923 1Springer publishes anthology with the Nanoethics Group 4923 2
...7 - CeNeS Pharmaceuticals (AIM:CEN),("CeNeS" or "t...,company today announced that a paper published th...hesis that a,catechol-O-methyltransferase (COMT) i...agent to address profound cognitive,deficits in sc...oing discovery programme to develop novel COMT inh...
...or Second Pivotal Phase 3 Trial CL-05, CHICAGO, Ju...e,Sciences Holdings, Inc. , today announced the co...l CL-06, the first of two,pivotal Phase 3 clinical...eness of cethromycin, a novel once-a-day antibioti...ia (CAP). The Company,also provided an update to t...
Other Medicine Technology:Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 2Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 3Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: